Syöpä
Early University of Calgary trial tests high-dose niacin as add-on treatment for glioblastoma
Raportoinut AI AI:n luoma kuva Faktatarkistettu
Researchers at the University of Calgary are studying whether high doses of vitamin B3 (niacin) can improve outcomes for patients with newly diagnosed glioblastoma when added to standard treatment. An interim analysis of 24 patients found a higher-than-expected six‑month progression‑free survival rate, though investigators stress the results are preliminary and require ongoing safety monitoring.
A San Francisco startup has begun testing a brain implant in humans that aims to detect and one day treat cancer. Three people have received the device so far.
Raportoinut AI Faktatarkistettu
A comprehensive review led by UNSW Sydney cancer researchers concludes that nicotine-based e-cigarettes are likely to cause cancers of the lung and oral cavity, drawing on evidence from human biomarkers, animal studies and laboratory research. The authors say long-term studies are still needed to quantify the level of risk in people who vape.
Women taking GLP-1 medications such as Ozempic and Wegovy showed about 30 percent lower odds of developing breast cancer in a large observational study.
Raportoinut AI
The CRIS Cancer Foundation will allocate the 3.6 million euros raised to Vega Oncotargets, the company founded by Mariano Barbacid. The decision follows a controversial campaign that generated excessive expectations about a pancreatic cancer treatment.
Researchers have developed 3D-printed gels that mimic lymph nodes to improve the production of CAR T-cells for cancer treatment. The approach increased success rates and sped up cell growth compared with standard methods. It may help lower costs and expand access to the therapy worldwide.
Raportoinut AI
Scientists are raising new questions about the relationship between vitamin B12 and cancer risk. While deficiency has long been known to increase dangers, recent studies suggest very high levels may also play a role.
Study finds excessive EXO1 DNA-repair activity can destabilize genomes and may mark tumors sensitive to some therapies
18. kesäkuuta 2026 16.29Oncolys president reflects on journey to world-first cancer treatment
12. kesäkuuta 2026 21.46Second report on Oncology Alert Plan shows 99.9% of patients contacted
12. kesäkuuta 2026 10.17Study finds blood-cancer-linked mutations in brain immune cells tied to Alzheimer’s pathology
11. kesäkuuta 2026 09.57Vaping after quitting smoking raises lung cancer death risk
4. kesäkuuta 2026 23.56New drug Daraxonrasib nearly doubles survival in pancreatic cancer trial
4. kesäkuuta 2026 18.22Princess of Wales hugs cancer survivor at Manchester hospital
1. kesäkuuta 2026 12.17Thymus health may predict longevity and cancer outcomes
31. toukokuuta 2026 16.22Hong Kong cancer death rate nearly halves over four decades
31. toukokuuta 2026 12.15Study finds melanoma spreads most in middle age